ZR-75-1 estrogen independent breast cancer cell line panel (1)

These cell lines are a powerful tool for studying the molecular and cellular mechanisms of breast tumour progression, therapy resistance and to test the effectiveness of novel drugs to combat different modes of anti-estrogen insensitivity.

Contributors

Institute
Erasmus University Medical Center (Erasmus MC)
Cat. #: 154644
Tool sub type: Continuous
Unit size: 1×10^6 cells / vial
Cancer types: Gynaecologic cancer
Research Fields: Cancer;Drug development
Organism: Human
Tissue: Breast
Model: Cancer Model
Cancer Types In Detail: Mammary ductal carcinoma
Alternate name: BCAR
Product description: Endocrine therapy of breast cancer has been applied widely and proven to be effective. However, in many instances endocrine treatments ultimately fail due to the development of an estrogen-independent therapy resistant phenotype. To elucidate the molecular mechanism underlying this endocrine therapy failure, the laboratory of Lambert Dorssers applied random insertional mutagenesis using defective retroviruses to identify individual genes conferring estrogen independence. Viral integrations were mapped within the human genome of the resulting panel of 71 tamoxifen-resistant cells lines (Cat No 154549-154619). Out of 15 candidate BCAR genes, seven were shown to directly underlie estrogen independence. These cell lines are a powerful tool for studying the molecular and cellular mechanisms of breast tumour progression, therapy resistance and to test the effectiveness of novel drugs to combat different modes of anti-estrogen insensitivity. In each cell line a single gene activated by the integration of the retrovirus underlies the resistant phenotype of that cell line.Since this panel of cell lines represents multiple ways to escape estrogen-dependent growth, new drugs can be tested for their effectiveness to block growth of the different escape routes.
Conditional: No
Production details: ZR-75-1 cells were infected with amphotropic, defective murine retrovirus and plated in medium containing 1uM of 4-hydroxy-tamoxifen. Within 5 weeks after the start of selection proliferating colonies were individually picked and expanded to stable cell lines. Each cell line has a unique set of retrovirus integrations, one of which is responsible for the phenotype
Parental cell line: ZR-75-1
disease: Cancer
Format: Frozen
Shipping conditions: Dry ice
Growth medium: RPMI 1640 medium supplemented with 10% heat-inactivated bovine calf serum (RBCS)
References:

van Agthoven et al. 2009. Breast Cancer Res Treat. 114(1):23-30. PMID: 18351453.

Dorssers et al. 1993. Mol Endocrinol. 7(7):870-8. PMID: 8413311.

Related Tools for Cell lines

Cat. # Tool Name
151479 HCT 116 p300 KO [D10] Cell Line Key Info View Tool
151503 1-7 CE1 Cell Line Key Info View Tool
151579 U-2 OS Gal4-p300 Cell Line Key Info View Tool
151630 PDVC57B Cell Line Key Info View Tool
151448 CMT 167 Cell Line Key Info View Tool

Related News

UM-UC-10 Cell Line. Image courtesy of the European Collection of Authenticated Cell Cultures (ECACC), UK.
Cell Lines

Popular cell lines now available only from CancerTools.org

Read More
Cell Lines

New cell lines: murine melanocyte and melanoblast cell lines from Dr. Elena Sviderskaya

Read More
Image Reference: 2x PTEN -/- mouse prostate cancer cell lines (MuCap system). Histology staining of syngraft tumours (Van Duijn et al., 2018).
Cell Lines

38 new prostate cancer cell lines

Read More

Tool enquiry

Please ensure you use your organisation email address rather than personal where possible, as this helps us locate your organisation in our system faster.

Please note we may take up to three days to respond to your enquiry.

CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.